Fibricor
FDA Approves New Kynamro for Inherited Cholesterol Disorder »
"The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemi"...
Read the FDA Approves New Kynamro for Inherited Cholesterol Disorder article »
Fibricor
FIBRICOR®
(fenofibric acid) Tablets
DRUG DESCRIPTION
FIBRICOR is a lipid regulating agent available as tablets for oral administration. Each tablet contains 35 mg or 105 mg of fenofibric acid. The chemical name for fenofibric acid is 2-[4-(4-chlorobenzoyl)phenoxy]-2methylpropanoic acid with the following structural formula:
 |
Fenofibric acid is a white to almost white crystalline powder that is stable under ordinary conditions, and has a melting point of 179 – 183°C. Its empirical formula is C17H15ClO4 and molecular weight 318.75. Fenofibric acid is insoluble in water; its solubility increases with pH in buffered media.
Inactive Ingredients: Each tablet contains copovidone, crospovidone, magnesium stearate and microcrystalline cellulose.
Last reviewed on RxList: 3/21/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Fibricor Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cholesterol Management
Tips to keep it under control.
Updated & New
